Cellworks Omics Biology Modeling (CBM) to predict therapy response and identifies novel biomarkers for carboplatin/cisplatin along with pemetrexed in NSCLC patients.

Ansu Kumar,Vamsidhar Velcheti,Michael Castro,Himanshu Grover,S. Mohapatra,Samiksha Avinash Prasad,Deepak Anil Lala,Chandan Kumar,Pallavi Kumari,Reshma P Gopi,Mamatha Patil,Shruthi Kulkarni,Nirjhar Mundkur,Annapoorna Prakash,Rema Mandal,Nagendra K Prasad,Sayantani Roy Choudhury,Anish Raju R Amara,Liptimayee Behura

Cellworks Omics Biology Modeling (CBM) to predict therapy response and identifies novel biomarkers for carboplatin/cisplatin along with pemetrexed in NSCLC patients.

2021

Ansu Kumar
Vamsidhar Velcheti
Michael Castro
Himanshu Grover
S. Mohapatra
Samiksha Avinash Prasad
Deepak Anil Lala
Chandan Kumar
Pallavi Kumari
Reshma P Gopi
Mamatha Patil
Shruthi Kulkarni
Nirjhar Mundkur
Annapoorna Prakash
Rema Mandal
Nagendra K Prasad
Sayantani Roy Choudhury
Anish Raju R Amara
Liptimayee Behura

e21211Background: Cancer management using cytotoxic drugs is hampered by limited efficacy. Hence, a personalized treatment approach matching chemotherapy with appropriate patients remains a persist...

Keywords:

Internal medicine
Medicine
therapy response
Oncology
personalized treatment
Pemetrexed
Chemotherapy
Omics
cancer management
Carboplatin/cisplatin

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations